Aberrant A‐to‐I RNA editing by ADAR1 has been linked to increased tumourigenesis and chemotherapy resistance in various cancers, including breast cancer,13 hepatocellular carcinoma,14 and colorectal cancer.15 This evidence concerns the gene ADAR and cancer.